Basit öğe kaydını göster

Tissue sialic acid and fibronectin levels in human prostatic cancer

dc.contributor.authorKaraaslan, I
dc.contributor.authorKokoglu, Emine Hakkı
dc.contributor.authorBaloglu, H
dc.contributor.authorSonmez, Hüseyin Avni
dc.contributor.authorSuer, S
dc.date.accessioned2021-03-06T08:42:05Z
dc.date.available2021-03-06T08:42:05Z
dc.date.issued1996
dc.identifier.citationSuer S., Sonmez H. A. , Karaaslan I., Baloglu H., Kokoglu E. H. , "Tissue sialic acid and fibronectin levels in human prostatic cancer", CANCER LETTERS, cilt.99, ss.135-137, 1996
dc.identifier.issn0304-3835
dc.identifier.otherav_e2370966-ea71-462a-b41e-10d64c4d1351
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/148903
dc.identifier.urihttps://doi.org/10.1016/0304-3835(95)04084-6
dc.description.abstractWe investigated the tissue concentration of sialic acid and fibronectin in patients with prostatic cancer. The mean sialic acid and fibronectin levels in patients with prostatic cancer were 19.02 +/- 6.30 mu g/mg protein and 20.22 +/- 7.13 mu g/mg protein, respectively versus 13.01 +/- 4.53 mu g/mg protein and 11.77 +/- 6.74 mu g/mg protein for normal prostatic tissues. Sialic acid and fibronectin levels in cancerous patients were significantly higher than in the control group (P < 0.05).
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleTissue sialic acid and fibronectin levels in human prostatic cancer
dc.typeMakale
dc.relation.journalCANCER LETTERS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume99
dc.identifier.issue2
dc.identifier.startpage135
dc.identifier.endpage137
dc.contributor.firstauthorID22883


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster